2 ASX shares you missed that had cracking results

Information overload during reporting season might have meant you failed to spot this pair of opportunities

| More on:
Three excited business people cheer around a laptop in the office

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

August results season is mayhem for investors.

There are so many different companies to follow. So many numbers to crunch. And so many decisions to make about your ASX shares.

There's no doubt it can be overwhelming. That's why even the veterans may miss something.

Fortunately, a couple of experts offered up an ASX stock each that retail investors might have missed.

They're both businesses that delivered in their 2021 financial year results, and have nice prospects for the future.

Record results, record profit, record dividend

Temple & Webster Group Ltd (ASX: TPW) certainly is the market darling as the online disruptor in the furniture retail sector.

That's why investors might have missed that old-timer Nick Scali Limited (ASX: NCK) delivered a pretty amazing report last month.

"This one has certainly delivered a record result and record profit, record dividend," 1851 Capital chief investment officer Chris Stott told a Livewire video.

"And it flew well under the radar from a share price perspective — it's fairly flat."

Indeed he is right. Nick Scali shares have only risen 1.3% in the past month.

According to Stott, the furniture vendor is "one of the best retailers in the country".

"The outlook we think is as good as we've ever seen for Nick Scali," he said. "Anthony Scali is running the business and has done this for well over 20 or 30 years."

The company has expressed interest in acquiring rival retailer Plush, which Stott considers a tailwind.

"If they do, it would be earnings accretive going forward. So we think there's certainly scope for M&A activity, as well as earnings to surprise on the upside in our opinion," he said. 

"We think that's a buy."

Nick Scali shares are up more than 26% this year, and 47.9% over the last 12 months.

ASX share to buy if you don't mind coal

Market Matters portfolio manager James Gerrish admits coal is on the nose with investors these days.

But he does like the look of one producer.

"I'm probably going to get shot by viewers here, but Whitehaven Coal Ltd (ASX: WHC)," he said. "Their result, while operationally and financially 2021 wasn't great, it's looking good for 2022."

Whitehaven shares have had a great run already. This year the price is up a whopping 71%, while the stock has rocketed 234% higher over the past 12 months.

For Gerrish, the best part of its August results was the progress in wiping out debt.

"They say if coal prices stay where they are, they'll be debt-free by the second half of '22, which I think is a really strong outcome," he said.

"It reminds me of Fortescue Metals Group Limited (ASX: FMG) when they had debt problems and then they got a really strong commodity price tailwind. So Whitehaven Coal is a stock to buy from me."

Whitehaven shares flew high on Friday, gaining 6.8%.

Should you invest $1,000 in Nick Scali Limited right now?

Before you buy Nick Scali Limited shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Nick Scali Limited wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 30 April 2025

Motley Fool contributor Tony Yoo owns shares of Temple & Webster Group Ltd. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Temple & Webster Group Ltd. The Motley Fool Australia has recommended Temple & Webster Group Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a rough trading day for ASX stocks this Monday.

Read more »

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
Broker Notes

Bell Potter names more of the best ASX 200 stocks to buy in May

These stocks could be best buys this month according to the broker.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

Oil worker using a smartphone in front of an oil rig.
Energy Shares

ASX 200 energy shares plunge on shock OPEC move

ASX 200 energy shares like Woodside and Santos are tumbling on Monday. Let’s find out why.

Read more »

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Share Gainers

Why 4DMedical, Gold Road, Syrah, and Tyro shares are racing higher today

These shares are starting the week strongly. But why?

Read more »

Rising gold share price represented by a green arrow on piles of gold block.
Gold

2 ASX gold stocks racing higher in Monday's sinking market

Investors are sending these ASX gold stocks flying higher on Monday. But why?

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Brainchip, Helia Group, Reliance Worldwide, and Westpac shares are dropping today

These shares are starting the week in the red. But why?

Read more »

Man looking upwards contemplating which shares to buy
Broker Notes

CSL shares have climbed 10% since 11 April. Is it too late to buy?

What are analysts saying about this biotech giant after its recent rally? Let's find out.

Read more »